Colorado Prevention Center
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1876-01-01
- Employees
- 9.4K
- Market Cap
- -
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 2600
- Registration Number
- NCT06033950
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 1500
- Registration Number
- NCT06024746
- Locations
- ๐บ๐ธ
Kansas City, MO Investigative Site, Kansas City, Missouri, United States
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Conditions
- Heart FailureAcute Heart Failure
- Interventions
- Drug: FinerenoneDrug: Placebo
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 5200
- Registration Number
- NCT06008197
- Locations
- ๐บ๐ธ
Aurora, CO Investigative Site, Aurora, Colorado, United States
๐บ๐ธDenver, CO Investigative Site, Denver, Colorado, United States
๐บ๐ธBoca Raton, FL Investigative Site, Boca Raton, Florida, United States
Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: Virta Health
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 60
- Registration Number
- NCT04807218
- Locations
- ๐บ๐ธ
Northwest Colorado Health - Community Health Center & Prevention Services Craig, Craig, Colorado, United States
๐บ๐ธHigh Plains Community Health Center, Lamar, Colorado, United States
๐บ๐ธChaffee County Public and Environmental Health, Salida, Colorado, United States
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients
- Conditions
- Peripheral Artery Disease
- Interventions
- Other: Intervention A - Vascular Care + site 6MWT administrationOther: Intervention A - Vascular Care + CPC EQuIP 6MWT administrationOther: Intervention B - Standard Care + CPC EQuIP 6MWT administrationOther: Intervention B - Standard Care + site 6MWT administration
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 166
- Registration Number
- NCT04400409
- Locations
- ๐บ๐ธ
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Evaluation of Cilostazol in Combination With L-Carnitine
- Conditions
- Peripheral Vascular DiseaseIntermittent ClaudicationPeripheral Arterial Disease
- Interventions
- Dietary Supplement: Levocarnitine tartrateDrug: cilostazol
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 164
- Registration Number
- NCT00822172
- Locations
- ๐บ๐ธ
HPV Heart, PA, Columbia, Maryland, United States
๐บ๐ธUniversity of Massachusetts Medical Center, Worcester, Massachusetts, United States
๐บ๐ธRadiant Research, Inc, Columbus, Ohio, United States
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
- Conditions
- AnginaPeripheral Arterial Disease
- Interventions
- Drug: PlaceboDrug: Ranolazine
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- Colorado Prevention Center
- Registration Number
- NCT00657514
- Locations
- ๐บ๐ธ
University of Colorado at Denver, Aurora, Colorado, United States
๐บ๐ธDenver Health and Hospital Authority (DHHA), Denver, Colorado, United States
๐บ๐ธDepartment of Veteran Affairs Medical Center, Denver, Colorado, United States